Cornerstone Pharmaceuticals

Open
1 Duncan Dr Ste 2
Cranbury, NJ 08512

Cornerstone Pharmaceuticals is a biopharmaceutical company based in Cranbury, NJ, focused on developing innovative antimetabolic therapies for cancer treatment. The company is currently advancing its lead drug candidate, CPI-613 (devimistat), through preclinical models to explore its efficacy in combination therapies.

With a commitment to research and development, Cornerstone Pharmaceuticals aims to revolutionize cancer care by targeting the metabolic pathways that fuel tumor growth. Their strategic approach reflects a dedication to improving patient outcomes through novel therapeutic solutions.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew JerseyCranburyCornerstone Pharmaceuticals

Partial Data by Infogroup (c) 2025. All rights reserved.